Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 13.
CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CenterWatch is a seven-time winner of the prestigious eHealthcare Leadership Award given annually to organizations representing the best web sites dedicated to health care. (PRWeb Nov 10, 2009)
Read the full story at http://www.prweb.com/releases/2009CenterWatch/eHealthcare/prweb3181264.htm
Source: PRWeb: Medical Pharmaceuticals - November 11, 2009 Category: Pharmaceuticals Source Type: news
InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac, an Animal Free Reagent for Bacterial FermentationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
InVitria's Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation. (PRWeb Nov 10, 2009)
Read the full story at http://www.prweb.com/releases/BacterialFermentation/chickenlysozymeHEWL/prweb3182554.htm
Source: PRWeb: Medical Pharmaceuticals - November 11, 2009 Category: Pharmaceuticals Source Type: news
Aprexis Health Solutions, Neighborhood Health Plan, and Medmetrics Health Partners Collaborate to Provide Adherence ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pioneer in medication adherence provides adherence support to hypertension patients. (PRWeb Nov 10, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3177304.htm
Source: PRWeb: Medical Pharmaceuticals - November 11, 2009 Category: Pharmaceuticals Source Type: news
Smith & Nephew to buy Nucryst Pharmaceuticals technologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Advanced Wound Management division of Smith & Nephew plc said it has signed a definitive agreement to acquire substantially all of the assets of Nucryst Pharmaceuticals Corp. (NCST) (SNN)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2009 Category: Pharmaceuticals Source Type: journals
BioElectronics Corporation: BioElectronics to Announce Results of Acetaminophen Comparison StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FREDERICK, MD (MARKET WIRE) BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced that results from the recently completed acetaminophen comparison study will be released on Monday, November 16th after the close of the market. The study compares the effects of ActiPatch(R) Therapy to acetaminophen in the form of Extra Strength Tylenol(R) for the treatment of Delayed Onset Muscle Soreness (DOMS).
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech BIEL Source Type: news
Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact LensesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO, Fla., Nov. 11 (HSMN NewsFeed) -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable clinical effects, new research shows.
More than half of frequent replac... Devices, OphthalmologyVISTAKON, Johnson & Johnson, contact lens
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
cutec PEG Hydrogel Contact Lenses Receive CE Mark ApprovalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Material Demonstrates Superior Oxygen Permeability and Water Binding Properties
ORLANDO, Fla.--(HSMN NewsFeed)--Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for... Devices, Ophthalmology, RegulatoryOcutec, polyethylene glycol, contact lens
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
BIOTRONIK, Inc., Names Dan Schlewitz Executive VP of SalesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sales Leader Brings Fast Track Experience to Rapidly Growing U.S. Cardiac Rhythm Management Company
LAKE OSWEGO, Ore.--(HSMN NewsFeed)--BIOTRONIK, Inc., announced today that they have named Dan Schlewitz as Executive Vice President of Sales for their U.... Devices, Cardiology, PersonnelBIOTRONIK, Cardiac Rhythm Management
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
myMatrixx: myMatrixx Renews Contract With Steven P. Stanos, Jr., DOEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TAMPA, FL (MARKET WIRE) myMatrixx(TM) today announced the extended appointment of Steven P. Stanos, Jr., DO, as Medical Director. Dr. Stanos is nationally recognized for his significant contributions to the fields of pain management and rehabilitation. This appointment represents the continued steps that myMatrixx is taking to not only position itself as the leader in technology driven efficiencies, but also position the company as a leader in clinical programs, specifically pain management outcomes.
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
All Children’s Hospital invites viewing of mega projectEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The new All Children’s Hospital in St. Petersburg is opening its doors to the public for tours.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2009 Category: Pharmaceuticals Source Type: journals
Unilife Medical Solutions: Unilife Announces Appointment of New Independent DirectorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) As announced on 1 September 2009, Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI) (PINKSHEETS: UNIFF) is currently undertaking a transaction to redomicile the Unilife group in the United States of America ("US") and is also seeking to list on NASDAQ.
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare UNI UNIFF Source Type: news
Cipla to export anti-Swine flu drugs to USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pharma firm Cipla Ltd said it is looking to export Antiflu, the drug used in the treatment of influenza AH1N1 (swine flu) virus, to US markets.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Anheuser-Busch gives $50,000 to Fisher House FoundationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
To honor Veteran’s Day, Anheuser-Busch’s Budweiser is donating $50,000 to Fisher House Foundation, a non-profit that builds homes for families of patients receiving medical care at military and VA hospitals.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2009 Category: Pharmaceuticals Source Type: journals
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTabEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Takeda Pharmaceuticals North America, Inc.'s Prevacid® (Lansoprazole) SoluTab. The Court found that Teva's generic lansoprazole orally disintegrating tablets do not infringe U.S. Patent No. 5,464,632.
Source: Pharma Industry News From Medical News Today - November 11, 2009 Category: Pharmaceuticals Tags: Litigation / Medical Malpractice Source Type: news
Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label ExtensionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Nov 10, 2009 - AVANIR
Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced efficacy,
safety and tolerability results from the 12-week open-label
extension phase of the confirmatory Phase III STAR trial...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide Studies at the Influenza Congress 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WEST HAVEN, Conn.--(BUSINESS WIRE)--Nov 9, 2009 - NanoViricides,
Inc. (OTC BB:
NNVC.OB) (the "Company"), announced today that the Company's
CEO, Eugene Seymour, MD, MPH, has been invited to participate in a
panel discussion at the Influenza...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
BioClinica to Host Medical Imaging Symposium for Rheumatoid Arthritis Clinical Trials on November 18, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- Company's Therapeutic Image Management Expertise Helps
Improve Clinical Trials Process -
NEWTOWN, Pa.--(BUSINESS WIRE)--Nov 10, 2009 - BioClinica™,
Inc., (NASDAQ: BIOC), a global provider of clinical trial services,
today announced it...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
SeniorBridge buys Melbourne companyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SeniorBridge, a service provider for individuals requiring care for chronic health conditions, is expanding its business in Florida with the acquisition of Senior Care Management Services in Melbourne.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2009 Category: Pharmaceuticals Source Type: journals
DUSA's Levulan PDT found to reduce squamous cell carcinomas by 95% in solid organ transplant recipientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDEPENDENT STUDY UTILIZING CYCLIC LEVULAN PDT FINDS 95 PERCENT
REDUCTION IN NEW SQUAMOUS CELL CARCINOMA LESIONS IN SOLID ORGAN
TRANSPLANT RECIPIENTS OVER A 2-YEAR PERIOD
WILMINGTON, Mass. (November 10, 2009) The results of an
independent...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
Analysis Underscores Financial Burden of Mental Illness on Criminal Justice and Health Care Systems(Nov 11, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Philadelphia, PA (November 11, 2009) – Results from a large, retrospective analysis of inmates with a serious mental illness (SMI) underscores the financial burden of mental illness on the criminal justice and health and human services (HHS) systems, and may provide useful information to policy makers. The results of the analysis, which evaluated patterns of arrest, utilization of services, and corresponding expenditures among nearly 3,800 inmates in a large urban county of Florida, were presented this week at the 137th
Source: Johnson and Johnson - November 11, 2009 Category: Pharmaceuticals Source Type: organizations
Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord InjuryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data Provide Preclinical Proof-of-Concept to Support Clinical
Development of GRNOPC1 in Patients With Cervical Spinal Cord
Injuries
MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 11, 2009 - Geron
Corporation (Nasdaq:GERN) today announced the...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st American Society of Hematology MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUMMIT, N.J.--(BUSINESS WIRE)--Nov 11, 2009 - Celgene
Corporation (NASDAQ: CELG) today announced that clinical
investigators from leading hematology research centers around the
world will present data from more than 200 recent and on-going
clinical...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
Crinone 8% (progesterone vaginal gel) As Effective as Hormone Injections During IVF? Is Medscape's ?Top News? from The ASRM 65th Annual MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Similar pregnancy rates and outcomes; time
has come for new paradigm in progesterone treatment for luteal
support, according to leading physician quoted by
Medscape
LIVINGSTON, N.J.--(BUSINESS WIRE)--Nov 9, 2009 - In their
American Society...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
India to WIPO chief: MNCs working against Indian drug firmsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
India on Wednesday complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign against country's pharmaceutical industry, which has broken their "cartel" in the generic drugs.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Exploring Powder Dispersion For Inhaled Drug ApplicationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Paul Kippax, product manager for diffraction systems at Malvern Instruments, is one of a group of powder dispersion and characterization experts who will speak in Leeds, UK, on 8 December 2009 at a meeting on 'Dispersion and Characterization of Dry Cohesive Powders for Inhalation and Particle Sizing'.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Tata Elxsi, NH in pact to develop healthcare solutionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tata Group company, Tata Elxsi has entered into an agreement with Bangalore-based Narayana Hrudayalaya to develop affordable healthcare solutions.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses(Nov 11, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, FL (November 11, 2009) – Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable clinical effects, new research shows.....
Source: Johnson and Johnson - November 11, 2009 Category: Pharmaceuticals Source Type: organizations
Cipla launches drug to treat H1N1 virusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug maker Cipla Ltd on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Integra Spine Launches the Paramount(R) Minimally Invasive System at the North American Spine Society MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLAINSBORO, N.J., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that it is featuring the Paramount(R) Pedicle Screw Fixation System for minimally invasive spine surgery at the annual North American Spine Society (NASS) Meeting, held November 10-14, 2009 in San Francisco, California. Integra acquired the Paramount(R) system in September 2009 as a result of the acquisition of certain assets of Innovative Spinal Technologies, Inc. (IST).
Source: Medical News (via PRIMEZONE) - November 11, 2009 Category: Pharmaceuticals Source Type: news
Coloplast to Sponsor the 2010 World Wheelchair Rugby ChampionshipsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HUMLEBAEK, Denmark, Nov. 11, 2009 (GLOBE NEWSWIRE) -- Coloplast is a major sponsor of the 2010 World Wheelchair Rugby Championships, which take place on 17 - 26 September in Vancouver, Canada.
Source: Medical News (via PRIMEZONE) - November 11, 2009 Category: Pharmaceuticals Source Type: news
Bayer strengthens sustainability commitmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Focus on the fields of health care, nutrition and climate protection / Eight lighthouse projects: More than 15 million people benefit directly / New technologies to reduce greenhouse gas emissions by five million metric tons per year / Management Board Chairman Wenning: “We are making specific contributions to balance commercial success with the protection of the environment and the needs of society”
Source: Bayer Company News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Right First Time: Pioneering New Methods Of Drug ManufactureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Dr Reddy's unit rev to grow 10-15 pc in FY10Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Reddy's Laboratories expects revenue at its pharmaceutical ingredients and outsourcing services unit to rise 10-15 per cent in this fiscal year, helped by stability in global economy, an official said.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Academy Launches Study On The Use Of Animals Containing Human MaterialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Academy of Medical Sciences has launched a new study to examine the use of
animals containing human material in scientific research.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
IACC Includes Vaccine Research Objective In Strategic Plan For Autism ResearchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Autism Speaks is encouraged by yesterday's decision of the Interagency Autism Coordinating Committee (IACC) to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research. The new language, approved unanimously, calls for studies to determine if there are sub-populations that are more susceptible to environmental exposures such as immune challenges related to naturally occurring infections, vaccines or underlying immune problems.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Westaim Announces Amalgamation Agreement With NUCRYST PharmaceuticalsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Westaim Corporation (TSX: WED) today announced the execution of an amalgamation agreement with NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Under the agreement, NUCRYST will amalgamate with a newly-formed, wholly-owned subsidiary of Westaim (the "Amalgamation").
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Nano draws biotech giant Alexandria to GujaratEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
US firm plans Rs 500 crore unit next to Tata Motors’ project.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Sanofi-aventis And Regeneron Expand Strategic Antibody CollaborationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Pandemic 2009 Influenza Update: US FDA Approves GSK's Pandemic H1N1 VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) recently announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.
Source: Pharmaceutical Online News - November 11, 2009 Category: Pharmaceuticals Source Type: news
How to Max Out Your Health BenefitsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Consumers should check that they're not leaving any health-insurance money on the table at the end of the year.
Source: WSJ.com: Health - November 11, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Stryker Announces Agreements To Acquire AssetsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
KALAMAZOO, Mich., Nov. 10 (HSMN NewsFeed) -- Stryker Corporation (NYSE: SYK ) announced today that it has acquired OtisMed Corporation, a privately held, software technology firm. OtisMed will focus on customizable instrumentation that has the potential ... Devices, Orthopaedic, AcquisitionsStryker, OtisMed
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
Daiichi to leverage Ranbaxy abroadEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Japan’s Daiichi Sankyo, which controls Ranbaxy Laboratories, will use the Indian company as a launch pad to sell its patented drugs in Europe, China and the US and will work together in developing new products, a senior company official said.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bristol-Myers Squibb Company (NYSE:BMY) and Alder Biopharmaceuticals, Inc., announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
Source: World Pharma News - November 11, 2009 Category: Pharmaceuticals Source Type: news
ETS Releases Free Whitepaper: Effects of an Ultraviolet B Radiation Absorber on Photocarcinogenesis in Hairless Albino MiceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Henk Tennekes, manager of ETS Nederland, has been involved in a recent study that explored the effects of an ultraviolet B radiation absorber on photocarcinogenesis in hairless albino mice.
To find out more about the aims, methods and results of the study click here to download the free whitepaper....
Source: Drug Development Technology - November 11, 2009 Category: Pharmaceuticals Source Type: info
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.
Source: GSK news - November 10, 2009 Category: Pharmaceuticals Source Type: organizations
NightHawk Radiology Holdings, Inc. to Speak at the Piper Jaffray 21st Annual Health Care Conference December 2, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SCOTTSDALE, Ariz., Nov. 10, 2009 (GLOBE NEWSWIRE) -- NightHawk Radiology Holdings, Inc. (Nasdaq:NHWK), the leading provider of radiology solutions to radiology groups and hospitals throughout the United States, today announced that it will present at the Piper Jaffray 21st Annual Health Care Conference at The New York Palace in New York, NY on Wednesday, December 2, 2009 at 12:30 p.m. eastern. Presenting at the conference will be David Sankaran, Chief Financial Officer. A live and archived webcast will be available on the investor relations section of NightHawk's website at http://www.nighthawkrad.net.
Source: Medical News (via PRIMEZONE) - November 10, 2009 Category: Pharmaceuticals Source Type: news
Discovery Labs to Present at the Lazard Capital Markets Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WARRINGTON, Pa., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that Thomas F. Miller, Ph.D., Senior Vice President of Corporate Development of Discovery Labs, will present an update on the Company's recent progress at the Lazard Capital Markets 6th Annual Healthcare Conference to be held in New York. The conference will be simultaneously webcast over the Internet.
Source: Medical News (via PRIMEZONE) - November 10, 2009 Category: Pharmaceuticals Source Type: news
